Raymond, A D <br/><br/>
Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.  [electronic resource] 

 -  Journal of neurovirology  Apr 2016 
 - 129-39 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-2443 
<br/><br/><label>Standard No.: </label>10.1007/s13365-015-0397-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood-Brain Barrier--drug effects<br/>Cell Line<br/>Chemokine CCL5--genetics<br/>Drug Carriers--pharmacology<br/>Endothelial Cells--cytology<br/>Escherichia coli--genetics<br/>Exosomes--metabolism<br/>Gene Expression Regulation<br/>Genes, Reporter<br/>Green Fluorescent Proteins--genetics<br/>HEK293 Cells<br/>HIV-1--chemistry<br/>Humans<br/>Interleukins--genetics<br/>Magnetite Nanoparticles--chemistry<br/>Microglia--cytology<br/>Models, Biological<br/>Peptides--chemical synthesis<br/>Signal Transduction<br/>Transfection<br/>Transgenes<br/>nef Gene Products, Human Immunodeficiency Virus--antagonists & inhibitors